Literature DB >> 19621455

Congenital aggressive variant of Langerhans cells histiocytosis with CD56+/E-Cadherin- phenotype.

Marco Lucioni1, Giampiero Beluffi, Laura Bandiera, Marco Zecca, Frediano Inzani, Giacomo Fiandrino, Alessandra Viglio, Mauro Stronati, Vittorio Necchi, Roberta Riboni, Franco Locatelli, Marco Paulli.   

Abstract

In children < 2 years of age, cutaneous involvement is the most frequent presentation of Langerhans cell histiocytosis (LCH). Cutaneous LCH can be localized or associated with dissemination and organ dysfunction. The clinical course is variable, ranging from spontaneous regression to a fatal outcome. We describe a female newborn presenting with congenital cutaneous lesions who rapidly developed pulmonary infiltrates and multiple osteolytic lesions. Skin biopsy showed a dermal infiltrate of medium to large cells morphologically and phenotypically consistent with LCH. The clinical course was rapidly fatal in spite of chemotherapy. No strict correlation between morphology and prognosis has been documented in LCH, but, in our case, distinct morphological and immunohistochemical features (CD56 expression and no E-Cadherin expression) may have contributed to an aggressive clinical course.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621455     DOI: 10.1002/pbc.22196

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  A Fatal Case of Congenital Langerhans Cell Histiocytosis with Disseminated Cutaneous Lesions in a Premature Neonate.

Authors:  Michio Inoue; Yoko Tomita; Tsuyoshi Egawa; Tomoaki Ioroi; Masaaki Kugo; Shinsaku Imashuku
Journal:  Case Rep Pediatr       Date:  2016-10-19

2.  Prognostic factors for histiocytic and dendritic cell neoplasms.

Authors:  Joji Shimono; Hiroaki Miyoshi; Fumiko Arakawa; Kensaku Sato; Takuya Furuta; Reiji Muto; Eriko Yanagida; Yuya Sasaki; Daisuke Kurita; Keisuke Kawamoto; Koji Nagafuji; Koichi Ohshima
Journal:  Oncotarget       Date:  2017-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.